Noted: The milk would be turned into powder and used in infant formula manufactured at an FDA-licensed facility in Billings, Montana, according to Linardakis.
He and Esselman were preparing FDA-required clinical studies for the formula, at University of Wisconsin-Madison, when COVID-19 shut down the research.